Our basic and clinical research has contributed to the development of pharmaceuticals that has included pivotal treatments for ocular herpes, corneal ulcers, and dry eyes. Read More
Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice May 17, 2013 - The study, led by James C. Iatridis, PhD, was published in the journal PLOS ONE on May 17.
Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh To Collaborate On Clinical Studies For Mucopolysaccharidoses May 15, 2013 - The company, based in Germany, is the sole producer of pharmaceutical pentosan polysulfate.
Mount Sinai Researchers Identify Gene Mutations in Congenital Heart Disease May 12, 2013 - Using high-throughput sequencing, an international research team including Mount Sinai discovers causes of severe congenital heart disease
